logo-loader
NASDAQ:ADMS

Adamas Pharmaceuticals Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$146.25 m
Price
5.25 USD
Change
-9.33%
52 weeks high
12.57
52 weeks low
3.35

In brief

Headquartered in Emeryville, California, Adamas Pharmaceuticals develops and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease.